Mode
Text Size
Log in / Sign up

Refractory ascites significantly reduces social, mental, and physical functioning in patients with advanced chronic liver diseaseRefractory ascites significantly lowers quality of life for liver patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that refractory ascites significantly reduces social, mental, and physical functioning in patients with liver disease.

This systematic review and meta-analysis evaluates the impact of refractory ascites on patient-reported outcomes (PROs) in patients with advanced chronic liver disease. The analysis included 1040 patients and 47 caregivers, comparing those with refractory ascites to stable outpatients with cirrhosis.

Findings indicate that patients with refractory ascites experience significantly lower scores across several domains. Specifically, SF-36 scores for social functioning were lower by 18.8 (95% CI: -30.2 to -7.3), mental health by 17.9 (95% CI: -33.5 to -2.3), and physical functioning by 13.6 (95% CI: -24.5 to -2.7). Additionally, scores for CLDQ abdominal symptoms (-1.5), activity (-0.9), worry (-1.2), and emotional function (-0.7) were significantly lower than those of stable outpatients.

The authors note a lack of validated tools for assessing PROs in this specific cohort. While the results highlight that refractory ascites significantly impacts health-related quality of life, the study does not provide specific clinical recommendations for a single assessment tool. Clinical relevance is centered on the significant impact of ascites on quality of life across multiple domains, noting that disease-specific tools were more sensitive than generic ones.

How this fits prior evidence

This meta-analysis addresses a gap in understanding the impact of refractory ascites on patient-reported outcomes. While previous coverage has focused on interventions like TIPS with embolization to reduce rebleeding and the use of statins to reduce mortality in cirrhosis, this study specifically quantifies the decline in quality of life for patients with refractory ascites. It confirms that the condition significantly impacts social, mental, and physical functioning compared to stable outpatients.

When a person lives with advanced chronic liver disease, the buildup of fluid in the abdomen, known as refractory ascites, does more than just cause physical discomfort. It can deeply impact how a person feels every day. A large review of data from over 1,000 patients and 47 caregivers shows that this condition leads to lower scores in mental health, social functioning, and physical ability compared to patients with stable liver disease.

Researchers looked at several ways to measure these impacts. They found that patients with fluid buildup reported lower scores in social functioning and mental health. They also reported lower scores in physical functioning and emotional health. While general health tools showed these declines, specific tools designed for liver disease were more sensitive at catching these changes.

It is important to note that the study highlights how much this condition affects daily life, but it does not recommend one specific tool over another. Because there is a lack of validated tools for some types of patient reports in this group, the findings serve as a clear look at the heavy burden these patients and their caregivers carry.

What this means for you:
Fluid buildup from advanced liver disease significantly lowers mental, physical, and social health for patients.

Common questions

How does fluid buildup affect a patient's daily life?

Patients with fluid buildup from advanced liver disease show lower scores in mental health, social functioning, and physical functioning compared to stable patients. They also report lower scores in emotional function and abdominal symptoms, showing the condition impacts many areas of daily life.

Does this condition affect the people caring for the patients?

The study included 47 caregivers in its analysis. While the data shows that the condition significantly impacts the patient's health-related quality of life, it highlights the heavy burden the condition places on the entire care circle.

Are there specific tools to measure these impacts?

The study found that disease-specific tools were more sensitive than generic ones at measuring how the condition affects quality of life. However, there is still a lack of some validated tools for certain types of patient reports in this specific group.

Study Details

Study typeMeta analysis
Sample sizen = 1,040
EvidenceLevel 1
PublishedNov 2026
View Original Abstract ↓
BACKGROUND: Refractory ascites (RA) secondary to advanced chronic liver disease (ACLD) results in poor health-related quality of life (HRQL), high symptom burden, and caregiver workload. Patient/caregiver-reported outcomes (PROs) remain uncharacterized in this cohort. This review summarises the available evidence on this topic. METHODS: MEDLINE/Embase/Cochrane/PsycINFO/Web of Science/CINAHL were searched for articles that included PROs in RA secondary to ACLD. A structured narrative synthesis and a meta-analysis were undertaken. RESULTS: Sixteen articles were included, comprising 1040 patients and 47 caregivers. Fourteen PRO measures were used, most commonly the Short Form-36 (SF-36) and the Chronic Liver Disease Questionnaire (CLDQ). Domain scores were pooled from 4 SF-36 and 3 CLDQ studies. Pooled domain scores were lower than those reported in stable outpatients with cirrhosis in 3/8 SF-36 domains: Social functioning (mean difference -18.8 [95% CI: -30.2 to -7.3]), Mental health (-17.9 [-33.5 to -2.3]), and Physical functioning (-13.6 [-24.5 to -2.7]); and 4/6 CLDQ domains: Abdominal symptoms (-1.5 [-2.3 to -0.7]), Activity (-0.9 [-1.4 to -0.5]), Worry (-1.2 [-2.1 to -0.3]), and Emotional function (-0.7 [-1.3 to -0.1]). Disease-specific tools had broader domain coverage and were more sensitive at picking up impairments in HRQL compared with generic ones. One symptom tool (the Ascites Questionnaire) had been validated in RA. The Short-Form Liver Disease Quality of Life questionnaire (SFLDQoL), the only HRQL measure validated in decompensated ACLD, was used once. Only 2 studies assessed informal caregivers. CONCLUSIONS: RA in ACLD detrimentally impacts HRQL across multiple domains. However, the lack of validated tools remains a barrier to assessing PROs and conducting well-designed RCTs in this cohort. This review highlights potential domains for the future development of such tools, which could drive equitable, patient-centered care in ACLD.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.